BHV-8000

· Biohaven Therapeutics Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHV-8000, covering 2026-01-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease [Phase 2, Phase 3]

See pricing